"Viagra For Women" Is Seeking FDA Approval For The Third Time

If men can take pills to boost their libido, why can't women?

That's what the FDA will be discussing on Thursday, June 4 — for the third time, reports The New York Times.

They will be discussing whether or not flibanserin — a drug more commonly known as "women's Viagra" — should be approved to treat low sexual desire in women. The biggest question on the table: Is sexual desire a human right?

Supporters, largely led by an effort called Even the Score, argue that this decision is based on gender equality, as women do not have the same resources as men when it comes to sexual dysfunction.

If approved, flibanserin would be the first drug to specifically address a low sex drive in women. There are 26 approved treatments of the same nature for men, according to the Times. So far, the agency has denied approval for the drug, saying that its benefits don't outweigh its potential side effects (like nausea and dizziness).

The meeting on Thursday will be open to the public. Let's hope that even if it's still deemed unsafe, the conversation about a woman's right to pleasure won't be shut down entirely.

Related Posts

Your article and new folder have been saved!